Clinical Trials Browser

Observational × camrelizumab × 90 days × Clear all

NCT05387512 2026-01-06

A Real World Study of β2-Adrenergic Blocker Plus PD-1 Inhibitor in Non-Small Cell Lung Cancer

Lung Neoplasms